Posted by on January 25, 2018 1:35 am
Categories: Crispr

Broad Institute wins bitter battle over CRISPR patents | QPT

The US Patent and Trademark Office (USPTO) has upheld a series of patents granted for CRISPR-Cas9 gene editing to the Broad Institute of MIT and Harvard.

The hotly anticipated decision could conclude a contentious battle between the Broad Institute in Cambridge, Massachusetts, and the University of California over intellectual property rights to the potentially lucrative technology. Although the Broad was awarded its patents first, the University of California was the first of the two to apply for a patent on the technology.

For now, the USPTO decision creates uncertainty for companies that may want to use CRISPR-Cas9 gene editing in eukaryotic cells.

If companies are forced to seek licenses from both sides, the cost of commercializing CRISPR-Cas9 gene editing could increase.
News Source:

Related Videos:
CRISPR Gene-Editing tested in a Person for the First time to cure Cancer in China
Using Light to control CRISPR Genome Editing
MIT Engineers program Human Cells to store complex Histories in their DNA
CRISPR: Gene Editing Will Change Everything Forever. Is this Genetic Engineering growth Good or Bad?
Curing disease by repairing faulty Genes. MIT boosts efficiency of CRISPR genome-editing system.
Gene Editing Tool “CRISPR Cas9” paves way for Sickle Cell Cure
Global CRISPR/Cas9 Market will Cross US$ 1.5 Billion by 2022
New gene-editing technology partially restores vision in blind animals
Scientists discover ‘off-switches’ for CRISPR/Cas9 gene editing

Leave a Reply